
Currently out of the existing stock ratings of Vamil Divan, 390 are a BUY (68.42%), 165 are a HOLD (28.95%), 15 are a SELL (2.63%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, has had 55.27% of price targets met with an average potential upside of 42.87%, reached in 331 days on average.
Vamil Divan has documented 1,100 price targets and ratings displayed on 57 stocks. The coverage is on Healthcare, Financial Services, Technology sectors.
Most recent stock forecast was given on ABSI, Absci Corp.
Analyst best performing recommendations are on ARAV (ARAVIVE).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) on 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%), with a performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$335
$39.97 (13.55%)
$325
1 days ago
(15-Nov-2026)
Buy Since 17-Nov-2020
$338
$42.97 (14.56%)
$282
15 days ago
(01-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 07-Dec-2021
$340
$44.97 (15.24%)
$300
15 days ago
(01-Nov-2026)
11/13 (84.62%)
$45.11 (15.30%)
479
Buy Since 05-Apr-2022
$346
$50.97 (17.28%)
$310
15 days ago
(01-Nov-2026)
33/35 (94.29%)
$51.11 (17.33%)
486
Buy Since 15-Nov-2023
$325
$29.97 (10.16%)
$290
15 days ago
(01-Nov-2026)
32/33 (96.97%)
$30.11 (10.21%)
244
Which stock is Vamil Divan most bullish on?
Which stock is Vamil Divan most reserved on?
What Year was the first public recommendation made by Vamil Divan?